These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31341161)

  • 21. Structural model of the hUbA1-UbcH10 quaternary complex: in silico and experimental analysis of the protein-protein interactions between E1, E2 and ubiquitin.
    Correale S; de Paola I; Morgillo CM; Federico A; Zaccaro L; Pallante P; Galeone A; Fusco A; Pedone E; Luque FJ; Catalanotti B
    PLoS One; 2014; 9(11):e112082. PubMed ID: 25375166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural insights into the conformation and oligomerization of E2~ubiquitin conjugates.
    Page RC; Pruneda JN; Amick J; Klevit RE; Misra S
    Biochemistry; 2012 May; 51(20):4175-87. PubMed ID: 22551455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Studies of HHARI/UbcH7∼Ub Reveal Unique E2∼Ub Conformational Restriction by RBR RING1.
    Dove KK; Olszewski JL; Martino L; Duda DM; Wu XS; Miller DJ; Reiter KH; Rittinger K; Schulman BA; Klevit RE
    Structure; 2017 Jun; 25(6):890-900.e5. PubMed ID: 28552575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis for transthiolation intermediates in the ubiquitin pathway.
    Kochańczyk T; Hann ZS; Lux MC; Delos Reyes AMV; Ji C; Tan DS; Lima CD
    Nature; 2024 Sep; 633(8028):216-223. PubMed ID: 39143218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylated Ubiquitin Modulates the Catalytic Activity of the E1 Enzyme Uba1.
    Lacoursiere RE; Shaw GS
    Biochemistry; 2021 Apr; 60(16):1276-1285. PubMed ID: 33848125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An essential yeast gene encoding a homolog of ubiquitin-activating enzyme.
    Dohmen RJ; Stappen R; McGrath JP; Forrová H; Kolarov J; Goffeau A; Varshavsky A
    J Biol Chem; 1995 Jul; 270(30):18099-109. PubMed ID: 7629121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity.
    Huang DT; Hunt HW; Zhuang M; Ohi MD; Holton JM; Schulman BA
    Nature; 2007 Jan; 445(7126):394-8. PubMed ID: 17220875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into noncanonical E1 enzyme activation from the structure of autophagic E1 Atg7 with Atg8.
    Hong SB; Kim BW; Lee KE; Kim SW; Jeon H; Kim J; Song HK
    Nat Struct Mol Biol; 2011 Nov; 18(12):1323-30. PubMed ID: 22056771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The basis for selective E1-E2 interactions in the ISG15 conjugation system.
    Durfee LA; Kelley ML; Huibregtse JM
    J Biol Chem; 2008 Aug; 283(35):23895-902. PubMed ID: 18583345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ubiquitin in motion: structural studies of the ubiquitin-conjugating enzyme∼ubiquitin conjugate.
    Pruneda JN; Stoll KE; Bolton LJ; Brzovic PS; Klevit RE
    Biochemistry; 2011 Mar; 50(10):1624-33. PubMed ID: 21226485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of the ubiquitin-activating enzyme loaded with two ubiquitin molecules.
    Schäfer A; Kuhn M; Schindelin H
    Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1311-20. PubMed ID: 24816100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitin manipulation by an E2 conjugating enzyme using a novel covalent intermediate.
    Merkley N; Barber KR; Shaw GS
    J Biol Chem; 2005 Sep; 280(36):31732-8. PubMed ID: 16014632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A General
    Zuo Y; Chong BK; Jiang K; Finley D; Klenerman D; Ye Y
    Biochemistry; 2020 Feb; 59(7):851-861. PubMed ID: 31951392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proximity-induced activation of human Cdc34 through heterologous dimerization.
    Gazdoiu S; Yamoah K; Wu K; Escalante CR; Tappin I; Bermudez V; Aggarwal AK; Hurwitz J; Pan ZQ
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15053-8. PubMed ID: 16210246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E2s: structurally economical and functionally replete.
    Wenzel DM; Stoll KE; Klevit RE
    Biochem J; 2011 Jan; 433(1):31-42. PubMed ID: 21158740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal mechanism of action for the Cdc34 acidic loop: a case study for why ubiquitin-conjugating enzymes have loops and tails.
    Ziemba A; Hill S; Sandoval D; Webb K; Bennett EJ; Kleiger G
    J Biol Chem; 2013 Nov; 288(48):34882-96. PubMed ID: 24129577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural analysis and evolution of specificity of the SUMO UFD E1-E2 interactions.
    Liu B; Lois LM; Reverter D
    Sci Rep; 2017 Feb; 7():41998. PubMed ID: 28165030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intragenic suppression among CDC34 (UBC3) mutations defines a class of ubiquitin-conjugating catalytic domains.
    Liu Y; Mathias N; Steussy CN; Goebl MG
    Mol Cell Biol; 1995 Oct; 15(10):5635-44. PubMed ID: 7565715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HIP2~ubiquitin conjugate forms a non-compact monomeric thioester during di-ubiquitin synthesis.
    Cook BW; Barber KR; Shilton BH; Shaw GS
    PLoS One; 2015; 10(3):e0120318. PubMed ID: 25799589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of an E3:E2~Ub complex reveals an allosteric mechanism shared among RING/U-box ligases.
    Pruneda JN; Littlefield PJ; Soss SE; Nordquist KA; Chazin WJ; Brzovic PS; Klevit RE
    Mol Cell; 2012 Sep; 47(6):933-42. PubMed ID: 22885007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.